PG officer exercises options, sells 15,169 shares
Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026.
Rhea-AI Filing Summary
Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026. He exercised 15,169 stock options at an exercise price of $91.07 per share, receiving the same number of common shares.
On the same day, he sold 15,169 common shares in an open-market transaction at a weighted average price of $162.2789 per share, within a price range of $162.26 to $162.311. Following these transactions, he held 44,735.4826 common shares directly, plus additional indirect holdings through a retirement plan and an international stock ownership plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,169 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,169 | $91.07 | $1.38M |
| Sale | Common Stock | 15,169 | $162.2789 | $2.46M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Weighted average price of the shares sold. The price range was $162.26 to $162.311. Full information regarding the number of shares sold at each separate price available upon request.
- F2. Reflects adjustment to PST through December 31, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Procter & Gamble (PG) executive Aguilar Moses do in this Form 4?
What stock options did Aguilar Moses exercise in this Procter & Gamble (PG) filing?
What role does Aguilar Moses hold at Procter & Gamble (PG) according to this Form 4?
How is the sale price described in Aguilar Moses’s Procter & Gamble (PG) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.